A main priority of Regenexx® is to decrease joint pain. Prior to receiving treatment, patients report average pain of nearly 5/10. After only 1-month, pain levels decrease to an average of 3.4/10, a decrease of 31%. Pain levels decrease further over time. The questionnaire used is the Numeric Pain Scale (NPS).    The number of patients reporting at these time-points are: 5175, 2778, 3002, 2534, 1816, 1302, 960, 579, 321.    *Data updated March 04, 2019